Personalized Estimate of Chemotherapy-Induced Nausea and Vomiting: Development and External Validation of a Nomogram in Cancer Patients Receiving Highly/Moderately Emetogenic Chemotherapy

Medicine
Zhihuang HuLi Zhang

Abstract

Chemotherapy-induced nausea and vomiting (CINV) is presented in over 30% of cancer patients receiving highly/moderately emetogenic chemotherapy (HEC/MEC). The currently recommended antiemetic therapy is merely based on the emetogenic level of chemotherapy, regardless of patient's individual risk factors. It is, therefore, critical to develop an approach for personalized management of CINV in the era of precision medicine.A number of variables were involved in the development of CINV. In the present study, we pooled the data from 2 multi-institutional investigations of CINV due to HEC/MEC treatment in Asian countries. Demographic and clinical variables of 881 patients were prospectively collected as defined previously, and 862 of them had full documentation of variables of interest. The data of 548 patients from Chinese institutions were used to identify variables associated with CINV using multivariate logistic regression model, and then construct a personalized prediction model of nomogram; while the remaining 314 patients out of China (Singapore, South Korea, and Taiwan) entered the external validation set. C-index was used to measure the discrimination ability of the model.The predictors in the final model included sex, age,...Continue Reading

References

May 13, 2004·Cancer·Steven M GrunbergGedske Daugaard
Nov 15, 2006·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Lorenzo CohenHenry Hu
Jun 6, 2008·The New England Journal of Medicine·Paul J Hesketh
Sep 17, 2009·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Paul J HeskethAlexandra D Carides
Sep 1, 2004·Journal of the National Comprehensive Cancer Network : JNCCN·Joseph A RoscoeAbhay R Shelke
Jun 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F RoilaUNKNOWN ESMO/MASCC Guidelines Working Group
Apr 6, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Felipe Melo CruzAuro del Giglio
Sep 29, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ethan BaschUNKNOWN American Society of Clinical Oncology
Mar 1, 2012·Journal of Clinical Psychopharmacology·Kevin Yi-Lwern YapUNKNOWN Onco-Informatics Group
Mar 8, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M AaproUNKNOWN PEER investigators
Mar 31, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·P Fernández-OrtegaA Llombart-Cussac
Apr 6, 2012·Current Opinion in Oncology·David Warr
Apr 12, 2012·Journal of the National Comprehensive Cancer Network : JNCCN·Sally Yowell Barbour
Jun 2, 2012·Journal of Palliative Medicine·Akito HataNaoto Kitajima
May 30, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·A MolassiotisE Kontopantelis
Nov 5, 2013·European Journal of Pharmacology·Camilo RojasBarbara S Slusher
Nov 28, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Zhihuang HuLi Zhang
Jan 15, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David M HymanAlexia Iasonos
Jul 13, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Emily S Van LaarAminah Jatoi
Aug 15, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Shiying YuDorothy M K Keefe
Aug 15, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Ruey Kuen HsiehDorothy M K Keefe
Aug 22, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Hoon-Kyo KimDorothy M K Keefe
Jan 28, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wenhua LiangJianxing He
Mar 11, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K JordanM Aapro
Jul 2, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Masakazu AbeKimihiko Ito
Aug 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M AaproUNKNOWN PEER investigators
Jun 1, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K JordanM Aapro

❮ Previous
Next ❯

Citations

Apr 17, 2020·Frontiers in Pharmacology·Abu Saleh Mohammad MosaIllhoi Yoo
Jun 25, 2021·The Tohoku Journal of Experimental Medicine·Xin-Juan HuangTao Wei
Oct 14, 2021·Cancer·Sylvia L CrowderHeather S L Jim

❮ Previous
Next ❯

Software Mentioned

SPSS
Package Hmisc
PrACTICE
R

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
A MolassiotisE Kontopantelis
Expert Opinion on Drug Metabolism & Toxicology
Rudolph M Navari
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Dorothy M K KeefeThomas A Burke
Expert Opinion on Pharmacotherapy
Rudolph M Navari
Expert Opinion on Emerging Drugs
Rudolph M Navari, Paula S Province
© 2022 Meta ULC. All rights reserved